Glossary

List price

The price a drug maker publishes before rebates and discounts; few payers pay it in full, but it can shape what some patients owe.

Also called: wholesale acquisition cost, WAC, sticker price, drug list price

A drug's list price is the price the manufacturer sets before discounts, usually reported as the wholesale acquisition cost, or WAC. It is the starting point for negotiation. Wholesalers, pharmacies, plans and government programs typically pay something different once discounts and a drug rebate are applied, which makes the "net price" lower than the list price.

As a labeled hypothetical, say a drug lists at $1,000 a month and rebates and discounts bring the net to $700. The plan's cost is $700, but with 30% coinsurance on the list price you would pay $300, not $210. If you have not met a high deductible, you may pay the full $1,000 until you do.

Because costs are tied to list price, a price increase can raise out-of-pocket spending even if the plan gets larger rebates. Manufacturers say list prices fund research and are offset by rebates; critics say the gap between list and net prices distorts incentives. Both views are part of the debate over the pharmacy benefit manager role.

The common mistake is treating the list price as the amount a plan pays. Ask what your plan uses to calculate your share.

Last reviewed November 16, 2026

In the index now

Related terms

Related guides

Related blog